BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38327032)

  • 1. Selective orexin 1 receptor antagonism does not affect effort-based responding for sucrose reward in rats.
    Bergamini G; Durkin S; Steiner MA
    J Psychopharmacol; 2024 Mar; 38(3):305-308. PubMed ID: 38327032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of orexin/hypocretin in conditioned sucrose-seeking in female rats.
    Cason AM; Aston-Jones G
    Neuropharmacology; 2014 Nov; 86():97-102. PubMed ID: 25036612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hindbrain orexin 1 receptors influence palatable food intake, operant responding for food, and food-conditioned place preference in rats.
    Kay K; Parise EM; Lilly N; Williams DL
    Psychopharmacology (Berl); 2014 Jan; 231(2):419-27. PubMed ID: 23978908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of orexin/hypocretin in conditioned sucrose-seeking in rats.
    Cason AM; Aston-Jones G
    Psychopharmacology (Berl); 2013 Mar; 226(1):155-65. PubMed ID: 23096770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.
    Sharf R; Sarhan M; Brayton CE; Guarnieri DJ; Taylor JR; DiLeone RJ
    Biol Psychiatry; 2010 Apr; 67(8):753-60. PubMed ID: 20189166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.
    Moorman DE; James MH; Kilroy EA; Aston-Jones G
    Brain Res; 2017 Jan; 1654(Pt A):34-42. PubMed ID: 27771284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil.
    Mohammadkhani A; Fragale JE; Pantazis CB; Bowrey HE; James MH; Aston-Jones G
    J Neurosci; 2019 Dec; 39(49):9831-9840. PubMed ID: 31641055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil.
    Mohammadkhani A; James MH; Pantazis CB; Aston-Jones G
    Brain Res; 2020 Mar; 1731():146461. PubMed ID: 31526801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the orexin/hypocretin system in ethanol conditioned place preference.
    Voorhees CM; Cunningham CL
    Psychopharmacology (Berl); 2011 Apr; 214(4):805-18. PubMed ID: 21107540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity.
    Olney JJ; Navarro M; Thiele TE
    Alcohol Clin Exp Res; 2015 Jan; 39(1):21-9. PubMed ID: 25623402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.
    Smith RJ; See RE; Aston-Jones G
    Eur J Neurosci; 2009 Aug; 30(3):493-503. PubMed ID: 19656173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar role of mPFC orexin-1 receptors in the acquisition and expression of morphine- and food-induced conditioned place preference in male rats.
    Jamali S; Zarrabian S; Haghparast A
    Neuropharmacology; 2021 Oct; 198():108764. PubMed ID: 34450116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.
    Wiskerke J; James MH; Aston-Jones G
    Brain Res; 2020 Mar; 1731():146222. PubMed ID: 31002819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orexin₁ receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats.
    Jupp B; Krivdic B; Krstew E; Lawrence AJ
    Brain Res; 2011 May; 1391():54-9. PubMed ID: 21439948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist.
    Cason AM; Aston-Jones G
    Psychopharmacology (Berl); 2013 Aug; 228(3):499-507. PubMed ID: 23494235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the efficacy of the selective orexin 1 receptor antagonist nivasorexant in an animal model of binge-eating disorder.
    Steiner MA; Botticelli L; Bergamini G; Micioni Di Bonaventura E; Gatfield J; Williams JT; Treiber A; Vaillant C; Cifani C; Micioni Di Bonaventura MV
    Int J Eat Disord; 2024 Mar; ():. PubMed ID: 38456603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.
    Riday TT; Fish EW; Robinson JE; Jarrett TM; McGuigan MM; Malanga CJ
    Brain Res; 2012 Jan; 1431():53-61. PubMed ID: 22133306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats.
    Richards JK; Simms JA; Steensland P; Taha SA; Borgland SL; Bonci A; Bartlett SE
    Psychopharmacology (Berl); 2008 Jul; 199(1):109-17. PubMed ID: 18470506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil.
    Porter-Stransky KA; Bentzley BS; Aston-Jones G
    Addict Biol; 2017 Mar; 22(2):303-317. PubMed ID: 26598295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System.
    Freeman LR; Bentzley BS; James MH; Aston-Jones G
    Int J Neuropsychopharmacol; 2021 Jan; 24(1):54-63. PubMed ID: 32496559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.